These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2265245

  • 41. Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.
    Laterveer L, van Damme J, Willemze R, Fibbe WE.
    Exp Hematol; 1993 Dec; 21(13):1621-7. PubMed ID: 8243564
    [Abstract] [Full Text] [Related]

  • 42. Prolonged thrombocytosis in mice after 5-fluorouracil results from failure to down-regulate megakaryocyte concentration. An experimental model that dissociates regulation of megakaryocyte size and DNA content from megakaryocyte concentration.
    Chenaille PJ, Steward SA, Ashmun RA, Jackson CW.
    Blood; 1990 Aug 01; 76(3):508-15. PubMed ID: 2378983
    [Abstract] [Full Text] [Related]

  • 43. Secondary cytokines interact in sequence with interleukin-1alpha (IL-1alpha) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed animals.
    Kovacs CJ, Evans MJ, Daly BM, Thomas-Patterson D, Johnke RM, Powell DS.
    J Interferon Cytokine Res; 1997 Aug 01; 17(8):453-60. PubMed ID: 9282825
    [Abstract] [Full Text] [Related]

  • 44. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
    Gallicchio VS, Hughes NK, Tse KF, Ling J, Gaines H, Bowen TE, Uluitu M.
    Int J Immunopharmacol; 1995 Nov 01; 17(11):865-78. PubMed ID: 8788116
    [Abstract] [Full Text] [Related]

  • 45. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K, Vos B, Kang-Er Z, Guiffre A, Seymour R, Gillis S.
    Cytokines Mol Ther; 1995 Mar 01; 1(1):47-55. PubMed ID: 9384663
    [Abstract] [Full Text] [Related]

  • 46. Interactions between recombinant human erythropoietin and serum factor(s) on murine megakaryocyte colony formation.
    Tsukada J, Misago M, Kikuchi M, Sato T, Ogawa R, Ota T, Oda S, Morimoto I, Chiba S, Eto S.
    Blood; 1992 Jul 01; 80(1):37-45. PubMed ID: 1611096
    [Abstract] [Full Text] [Related]

  • 47. In vivo hematopoietic effects of recombinant interleukin-1 alpha in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin.
    Johnson CS, Keckler DJ, Topper MI, Braunschweiger PG, Furmanski P.
    Blood; 1989 Feb 15; 73(3):678-83. PubMed ID: 2783864
    [Abstract] [Full Text] [Related]

  • 48. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS, Plunkett JM, Schendel P, van de Ven C.
    Exp Hematol; 1994 Oct 15; 22(11):1118-23. PubMed ID: 7523164
    [Abstract] [Full Text] [Related]

  • 49. The induction of interleukin-6 (IL-6) and colony-stimulating factors (CSFs) by FK565 and its thrombopoietic activity following in vivo administration.
    Maeda M, Suzuki S, Ohtsuka K, Satoh S, Nishigaki F, Shimomura K, Imai Y, Niwa M, Kohsaka M.
    Biol Pharm Bull; 1994 Feb 15; 17(2):173-9. PubMed ID: 7515742
    [Abstract] [Full Text] [Related]

  • 50. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct 15; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 51. Alterations in megakaryocyte and platelet compartments following in vivo IL-1 beta administration to normal mice.
    Williams DE, Morrissey PJ.
    J Immunol; 1989 Jun 15; 142(12):4361-5. PubMed ID: 2786031
    [Abstract] [Full Text] [Related]

  • 52. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
    Muench MO, Schneider JG, Moore MA.
    Exp Hematol; 1992 Mar 15; 20(3):339-49. PubMed ID: 1373685
    [Abstract] [Full Text] [Related]

  • 53. Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities.
    Emerson SG, Yang YC, Clark SC, Long MW.
    J Clin Invest; 1988 Oct 15; 82(4):1282-7. PubMed ID: 3049674
    [Abstract] [Full Text] [Related]

  • 54. Platelet-derived growth factor enhances granulopoiesis via bone marrow stromal cells.
    Yang M, Li K, Lam AC, Yuen PM, Fok TF, Chesterman CN, Chong BH.
    Int J Hematol; 2001 Apr 15; 73(3):327-34. PubMed ID: 11345198
    [Abstract] [Full Text] [Related]

  • 55. Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF.
    McNiece I, Andrews R, Stewart M, Clark S, Boone T, Quesenberry P.
    Blood; 1989 Jul 15; 74(1):110-4. PubMed ID: 2473792
    [Abstract] [Full Text] [Related]

  • 56. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S, Nakao I, Tsuneoka K, Nara N.
    Exp Hematol; 1989 Sep 15; 17(8):883-8. PubMed ID: 2475360
    [Abstract] [Full Text] [Related]

  • 57. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation.
    Elkordy M, Crump M, Vredenburgh JJ, Petros WP, Hussein A, Rubin P, Ross M, Gilbert C, Modlin C, Meisenberg B, Coniglio D, Rabinowitz J, Laughlin M, Kurtzberg J, Peters WP.
    Bone Marrow Transplant; 1997 Feb 15; 19(4):315-22. PubMed ID: 9051240
    [Abstract] [Full Text] [Related]

  • 58. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
    Dai CH, Krantz SB, Dessypris EN, Means RT, Horn ST, Gilbert HS.
    Blood; 1992 Aug 15; 80(4):891-9. PubMed ID: 1498332
    [Abstract] [Full Text] [Related]

  • 59. Thrombocytosis as a response to high interleukin-6 levels in cGMP-dependent protein kinase I mutant mice.
    Zhang L, Lukowski R, Gaertner F, Lorenz M, Legate KR, Domes K, Angermeier E, Hofmann F, Massberg S.
    Arterioscler Thromb Vasc Biol; 2013 Aug 15; 33(8):1820-8. PubMed ID: 23788765
    [Abstract] [Full Text] [Related]

  • 60. Recombinant GM-CSF/IL-3 fusion protein: its effect on in vitro human megakaryocytopoiesis.
    Bruno E, Briddell RA, Cooper RJ, Brandt JE, Hoffman R.
    Exp Hematol; 1992 May 15; 20(4):494-9. PubMed ID: 1373690
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.